A new research paper was published in Volume 16 of Oncotarget on July 21, 2025, titled “Statins exhibit anti-tumor potential ...

Indian scientists have discovered the molecular system controlling hair growth, potentially ending the need for transplants by enabling natural hair regrowth.

Ciprofol, an innovative anesthetic derived from propofol, has not yet been studied in detail regarding its effects in colorectal cancer (CRC). This study mainly explored the effects of Ciprofol on the ...

“Activation of b-catenin or loss of its negative suppressor APC play a key role in colorectal cancer, and we have previously shown that NT219 efficiently blocks the IRS2 to b-catenin pathway ...

The Wnt signaling pathway is known to be a key regulator of the expression of ECM-related genes; for example, vcan is directly regulated by the Wnt/b-catenin and tcf4 signaling pathways, leading to ...

The following is a summary of “Nur77 Promotes Inflammation in Cisplatin-Induced Acute Kidney Injury Through Transactivation of SERPINA3 Mediating Wnt/β-Catenin Pathway,” published in the February 2025 ...

The Wnt/β-catenin signaling pathway serves as a fundamental regulator of liver tissue homeostasis, orchestrating various cellular processes crucial for liver function and repair, especially in ...

Minoxidil penetrates through various pathways as an anti-inflammatory agent, an anagen extender, a 5-a reductase inhibitor and antiandrogen, an inducer of the Wnt/b-catenin signaling pathway, and ...

NORE1A has multiple roles in controlling cellular homeostasis, one of them being regulating levels of β-catenin by binding and modulating the ubiquitin ligase substrate recognition factor β-TrCP.

The Wnt/b-catenin signaling pathway can induce the onset of anagen and regulates the hair cycle. 3 There is evidence this pathway is significant to the role of morphogenesis and the regeneration ...

We observed the enhanced expression of genes involved in the EHMT2 and WNT/β-catenin pathways. In addition, we demonstrated that EHMT2 increases methylation of the SFRP1 promoter region to reduce ...

These new forms could potentially allow Terran to pursue accelerated development and regulatory strategies such as the FDA 505 (b) (2) approval pathway. Recent clinical trials of an oral, twice-daily, ...